You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: April 14, 2026

Profile for Chile Patent: 2011002430


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Chile Patent: 2011002430

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Jun 11, 2030 Biomarin Pharm VOXZOGO vosoritide
⤷  Start Trial May 20, 2030 Biomarin Pharm VOXZOGO vosoritide
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of the Scope, Claims, and Patent Landscape of Chilean Patent CL2011002430

Last updated: August 4, 2025

Introduction

Chilean patent CL2011002430 pertains to a pharmaceutical invention registered under Chile’s national patent system. As part of a comprehensive patent landscape analysis, this report dissects its scope, elucidates claim structure, and contextualizes its position within the global and regional pharmaceutical patent landscape. Understanding these facets informs key strategic decisions for stakeholders such as pharmaceutical companies, patent attorneys, and research entities.

Patent Overview and Filing Details

Patent CL2011002430 was filed with the Chilean Institute of Industrial Property (INAPI). The application’s filing date underscores the period's technological and legal environment, providing clues on the patent's longevity and renewal terms. Chile's patent law adheres closely to international standards, including compliance with the Patent Cooperation Treaty (PCT), which influences claim drafting and strategic positioning.

Scope of the Patent

The scope defines the invention’s territorial and legal boundaries, primarily articulated through its claims. This patent likely covers a pharmaceutical compound or formulation, extending to specific methods of manufacturing or therapeutic use.

The scope's breadth depends on claim language precision:

  • Broad claims might encompass the compound or therapeutic method in a general form.
  • Narrow claims specify particular chemical structures, dosage forms, or treatment regimes.

In Chile, the scope is influenced by the requirement to balance novelty and inventive step, preventing overly broad claims that could be invalidated for lacking specificity or clarity.

Claim Structure Analysis

1. Independent Claims

  • Typically, the patent’s core claims define the chemical entity, composition, or method.
  • They establish the minimum scope of protection.

2. Dependent Claims

  • These specify particular embodiments, such as specific salts, formulations, or therapeutic applications.
  • They narrow claims to particular variants, providing fallback positions should broader claims be rejected.

Given common practices, this patent likely includes:

  • An independent claim covering a novel compound or composition.
  • Additional claims dependent on the main claim, detailing specific salts, formulations, or uses.

3. Claim Language and Clarity

Effective claim drafting employs precise language to delineate boundaries clearly. For example:

  • Use of chemical nomenclature to specify molecular structures.
  • Definitions of use cases, such as anti-inflammatory, anticancer, or antiviral applications.
  • Method claims describing synthesis or administration procedures.

Clarity and consistency in language are critical to withstand legal challenges and facilitate enforcement.

Patent Landscape Context

Regional and International Patent Environment

Chile’s pharmaceutical patent landscape is characterized by:

  • Innovation activity: The patent likely stems from local or foreign pharmaceutical R&D investments.
  • Patent family status: It may be part of a broader patent family filed in multiple jurisdictions, including PCT applications.
  • Legal status: The patent’s validity depends on prosecution history, post-grant maintenance, and potential oppositions.

Chile aligns its patent laws with international standards, offering a 20-year patent term from filing, subjected to maintenance fees. The landscape features:

  • Strong competitors: Established global pharma corporations with patent portfolios in Latin America.
  • Local innovation: Chilean companies or universities filing patents for region-specific needs.
  • Generic challenges: Once patents expire, generic manufacturers prepare for market entry, emphasizing the importance of patent robustness.

Comparison with Global Patent Trends

  • The invention possibly coincides with international patent filings, especially in key markets such as the US, EU, and PCT Membership Countries.
  • Alignment with global patent strategies involves securing broad claims, especially in the face of potential patent challenges or for licensing opportunities.

Legal and Policy Considerations

  • Chile’s compliance with international treaties like the TRIPS Agreement influences patent scope, especially regarding pharmaceutical innovations.
  • Recent legislative amendments aim to balance patent rights with public health considerations, affecting patent enforcement strategies.

Strategic Implications and Patent Landscape Position

Innovator Strategy:

  • To maximize protection, applicants align claims with global filings.
  • Supplementary protection certificates (SPCs) are not available in Chile but may be pursued in other jurisdictions.
  • Licensing agreements may hinge on the patent's claim breadth and enforceability.

Patent Challenges and Litigation Trends:

  • Chile’s patent system has seen disputes involving challenge proceedings, emphasizing the importance of robust, well-drafted claims.
  • Prior art searches and validity opinions are crucial in defending patent claims, particularly in a landscape with significant generic competition post-expiry.

Key Takeaways

  • Claim Precision is central to enforceability: The patent’s claims should be carefully drafted to balance broad coverage with clarity and novelty.
  • Strategic Patent Family Planning enhances regional and international protection: Aligning Chilean filings with broader patent portfolios facilitates enforcement and monetization.
  • Robust Examination and Validation ensure patent validity: Engaging with experienced patent counsel during prosecution improves claim strength.
  • Market Timing and Lifecycle Management: Ensuring patent maintenance and considering supplementary protections optimize commercial benefits.
  • Monitoring Patent Landscape Trends aids in navigating challenges and identifying licensing or partnership opportunities.

Conclusion

Patent CL2011002430 exemplifies a typical pharmaceutical invention protected under Chilean patent law. Its scope and claims reflect strategic considerations regarding novelty, inventive step, and enforceability. The patent landscape in Chile presents opportunities and challenges requiring vigilant management, particularly in a context of regional and global patent activities. Stakeholders must ensure robust claim drafting, continuous portfolio analysis, and strategic protection to maximize the patent’s value.


Frequently Asked Questions

  1. What are the main factors affecting the validity of Chilean pharmaceutical patents like CL2011002430?
    Factors include the novelty, inventive step, detailed claim drafting, prior art references, and adherence to procedural requirements during prosecution.

  2. How does Chile’s patent law influence the scope of pharmaceutical patents?
    Chile’s law requires clarity, novelty, and inventive step, leading to precise and well-supported claims that avoid overly broad formulations vulnerable to invalidation.

  3. Can a patent like CL2011002430 be enforced in other Latin American countries?
    Enforcement depends on regional agreements; Chile is a member of the Andean Community and supports international treaties, but patent grants are jurisdiction-specific, requiring separate filings or regional strategies.

  4. What strategies should patentees adopt to extend protection beyond the standard 20-year term?
    Options include pediatric extension, supplementary protections, or developing additional patents on formulations or indications, to extend market exclusivity.

  5. What role do patent landscapes play in drug development and commercialization?
    They inform R&D direction, licensing opportunities, potential infringement risks, and strategic filing decisions, thus crucial for informed business planning.


References

  1. INAPI Patent Database
  2. World Intellectual Property Organization (WIPO) Patent Data
  3. Chilean Patent Law and Regulation Documentation

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.